Mental health has increasingly become the topic of discussion in recent years, and while we–as a society–have become better at recognizing the signs of mental health issues, have you ever wondered exactly what they are, how they are treated, and what happens if the tools available to us aren’t enough? You might be surprised to hear that–by some estimates–at least 30% of people diagnosed with depression are resistant to the current options we have. That’s where our guest, Dr. Charles Nemeroff, and his research on psychedelic compounds come into play. In this episode, you will learn about depression and PTSD, the prevalence of treatment-resistant depression, and the promising research around psilocybin and its future potential as a therapeutic. You can learn more about Dr. Nemeroff’s research on his website.
Additionally, you can follow Drew & Liv on Instagram @scienceinsociety to stay in the know on upcoming episodes, new content, and their ~nearly~ famous science shenanigans.
The National Mental Health Hotline: 1-866-903-3787